Fig. 1 · Structure

Documents & Downloads

Sodium dichloroacetate (DCA)

Cat. No. A17862 CAS 2156-56-1

Pyruvate dehydrogenase kinase inhibitor

Sodium Dichloroacetate, also known as CPC-211; DCA; X-11S, is a Pyruvate dehydrogenase kinase inhibitor potentially for the treatment of myocardia ischemia, ischemic. Sodium dichloroacetate also exhibits anti-leukemic activity in B-chronic lymphocytic leukemia (B-CLL) and synergizes with the p53 activator Nutlin-3. Sodium dichloroacetate (DCA) reduces apoptosis in colorectal tumor hypoxia.

In Stock

Free Aliquoting for Your Order

Tell us your preferred amount per vial. We’ll confirm the options.

Biological Activity

Cellular Effect

Cell Line Activity Value Description Reference
4T1 IC50 > 100 μM Anticancer activity against mouse 4T1 cells expressing PDK assessed as reduction in cell viability after 72 hrs by MTT assay [PMID: 31509699]
A-375 IC50 > 100 μM Anticancer activity against human A375 cells expressing PDK assessed as reduction in cell viability after 72 hrs by MTT assay [PMID: 31509699]
A-375 IC50 20.1 mM Antiproliferative activity against human A375 cells assessed as growth inhibition after 72 hrs by MTT assay [PMID: 33550182]
A549 IC50 1011 μM Anticancer activity against human A549 cells after 72 hrs by MTT assay [PMID: 20663593]
A549 IC50 19.5 mM Antiproliferative activity against human A549 cells assessed as growth inhibition after 72 hrs by MTT assay [PMID: 33550182]
A549 IC50 20.1 mM Antiproliferative activity against human A549 cells assessed as reduction in cell viability after 72 hrs by MTT assay [PMID: 30470491]
A549 IC50 23.58 mM Cytotoxicity against human A549 cells assessed as growth inhibition after 72 hrs by MTT assay [PMID: 27006991]
A549 IC50 4286 μM Cytotoxicity against human A549 cells after 68 hrs by MTT assay [PMID: 23067553]
Bel-7402 IC50 860 μM Anticancer activity against human Bel7402 cells after 72 hrs by MTT assay [PMID: 20663593]
BGC-823 IC50 1051 μM Anticancer activity against human BGC823 cells after 72 hrs by MTT assay [PMID: 20663593]
HCT-116 IC50 > 100 μM Anticancer activity against human HCT116 cells expressing PDK assessed as reduction in cell viability after 72 hrs by MTT assay [PMID: 31509699]
HCT-116 IC50 9.8 mM Antiproliferative activity against human HCT-116 cells assessed as growth inhibition after 72 hrs by MTT assay [PMID: 33550182]
KB IC50 1424 μM Anticancer activity against human KB cells after 72 hrs by MTT assay [PMID: 20663593]
KB 3-1 IC50 5883 μM Cytotoxicity against human KB-3-1 cells after 68 hrs by MTT assay [PMID: 23067553]
L02 IC50 > 100 μM Cytotoxicity against human LO2 cells assessed as reduction in cell viability after 72 hrs by MTT assay [PMID: 31509699]
L02 IC50 21.7 mM Cytotoxicity against human L02 cells assessed as reduction in cell viability after 72 hrs by MTT assay [PMID: 33550182]
MCF7 IC50 > 100 μM Anticancer activity against human MCF7 cells overexpressing PDK assessed as reduction in cell viability after 72 hrs by MTT assay [PMID: 31509699]
MCF7 IC50 12.35 mM Cytotoxicity against human MCF7 cells assessed as growth inhibition after 72 hrs by MTT assay [PMID: 27006991]
MCF7 IC50 13.4 mM Antiproliferative activity against human MCF7 cells assessed as growth inhibition after 72 hrs by MTT assay [PMID: 33550182]
NCI-H1650 IC50 16.3 mM Antiproliferative activity against human NCI-H1650 cells assessed as reduction in cell viability after 72 hrs by MTT assay [PMID: 30470491]

20 records · Scroll to view more

Specifications

Manufacturer Adooq Bioscience
Actions Inhibitor
CAS Number 2156-56-1
Applications Pyruvate dehydrogenase kinase inhibitor
Formula C2HCl2NaO2
Molecular Weight 150.92
Synonyms CPC-211; DCA; X-11S; Dichloroacetic acid.
SMILES
O=C([O-])C(Cl)Cl.[Na+]

Storage & Solubility

In Vitro Solubility

Reported Solubility

SolventReported Solubility
DMSO 27 mg/mL (178.9 mM)
Water 27 mg/mL (178.9 mM)
Ethanol 27 mg/mL

Preparing Stock Solutions

Stock preparation is unavailable for this product molecular weight.

Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.

Storage

Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.

Added to your cart

View Cart Checkout
Loading...